Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengjuan Fan

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Eclinicalmedicine|June 17, 2025
Risk of cardiovascular disease among cancer survivors: systematic review and meta-analysisQian Li, Guofu Zhang, Xiating Li, et al.
Breast Cancer Research and Treatment|October 31, 2018
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancerSonia Vallet, Fengjuan Fan, Stefano Malvestiti, et al.
International Journal of Cancer|September 15, 2017
MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signalingBo Tang, Aoshuang Xu, Jian Xu, et al.
Journal of Hepatology|May 11, 2010
Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22Ling Yang, Yixuan Zhang, Lingdi Wang, et al.
Medcomm|June 28, 2024
Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartumQian Li, Hongfei Wang, Huafang Wang, et al.
Blood Advances|July 23, 2024
Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myelomaJiasi Zhang, Yuxi Liu, Liping Zuo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2019
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple MyelomaJian Xu, Yan Su, Aoshuang Xu, et al.
Cancer Letters|October 15, 2013
Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulationFengjuan Fan, Giovanni Tonon, Muhammad Hasan Bashari, et al.
Blood Cancer Journal|August 19, 2024
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activityJudith Lind, Osman Aksoy, Michaela Prchal-Murphy, et al.
Cell|December 6, 2005
A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcriptionJiuhong Kang, Yufeng Shi, Bin Xiang, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Eclinicalmedicine|June 17, 2025
Risk of cardiovascular disease among cancer survivors: systematic review and meta-analysisQian Li, Guofu Zhang, Xiating Li, et al.
Breast Cancer Research and Treatment|October 31, 2018
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancerSonia Vallet, Fengjuan Fan, Stefano Malvestiti, et al.
International Journal of Cancer|September 15, 2017
MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signalingBo Tang, Aoshuang Xu, Jian Xu, et al.
Journal of Hepatology|May 11, 2010
Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22Ling Yang, Yixuan Zhang, Lingdi Wang, et al.
Medcomm|June 28, 2024
Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartumQian Li, Hongfei Wang, Huafang Wang, et al.
Blood Advances|July 23, 2024
Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myelomaJiasi Zhang, Yuxi Liu, Liping Zuo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2019
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple MyelomaJian Xu, Yan Su, Aoshuang Xu, et al.
Cancer Letters|October 15, 2013
Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulationFengjuan Fan, Giovanni Tonon, Muhammad Hasan Bashari, et al.
Blood Cancer Journal|August 19, 2024
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activityJudith Lind, Osman Aksoy, Michaela Prchal-Murphy, et al.
Cell|December 6, 2005
A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcriptionJiuhong Kang, Yufeng Shi, Bin Xiang, et al.
Pageof 6